Is RSD Genetic? Exploring Hereditary Links

Reflex sympathetic dystrophy (RSD) is the older name for complex regional pain syndrome (CRPS), a condition involving persistent pain, altered sensation, swelling, temperature or colour changes, and sometimes movement or skin changes in a limb. It is not automatically inherited, and the shorthand “RSD gene” is misleading.

Research does suggest that genetic differences may influence who develops CRPS after an injury or other trigger. These differences appear to affect susceptibility rather than determine a person’s fate, so inherited risk is best understood as one part of a broader medical picture.

Family history can still be clinically useful, particularly when several relatives have unexplained chronic pain, sensory symptoms or weakness. The goal is not to label relatives, but to identify whether an inherited nerve or metabolic condition needs specialist assessment while providing appropriate care for possible CRPS.

Genetic inheritance and family risk

RSD does not usually follow a simple dominant, recessive or sex-linked pattern like some single-gene disorders. Most people with CRPS have no affected close relative, and a child or sibling of someone with the condition is not generally considered at high risk of developing it.

Genetics nevertheless may influence biological vulnerability. Studies have found associations involving many genes, including pathways related to immune activity, pain processing, autonomic function and the stress response. Such findings show a possible inherited component, but they do not establish that one variant causes CRPS.

This distinction matters because polygenic risk is not the same as a directly testable family pattern. Genetic results can overlap with the general population and cannot currently predict whether an individual will develop CRPS. A person’s age, injury, treatment history and other health conditions remain important alongside family background.

What research says about familial links

Familial CRPS is uncommon but has been documented in small clusters and individual reports. Researchers have also studied families in which more than one member developed chronic regional pain, looking for shared biological traits and differences in symptom patterns.

Those observations do not prove straightforward vertical inheritance. Shared genes, a similar injury, household conditions or even diagnostic attention could contribute to clustering. Rare inherited disorders can also resemble CRPS, so a family pattern may warrant review by a clinical geneticist rather than an assumption that everyone has the same syndrome.

When relatives have unusual sensory loss, progressive weakness, early-onset symptoms or a known inherited nerve condition, targeted genetic testing may be appropriate. Such testing should follow a clinical assessment and genetic counselling; broad consumer DNA results are not a substitute for specialist diagnosis.

Triggers, environment and inherited susceptibility

In many cases, CRPS begins after a noxious event, such as a fracture, sprain, surgery, injection or prolonged immobilisation. Sometimes no clear trigger is found. Genetic susceptibility may affect how the nervous and immune systems respond to such events, but having a predisposing variant does not mean the condition will follow.

The same event affects different people very differently. Previous pain, limited movement, infection, other neurological illness and delays in treatment may influence the course, although the reasons are complex and still being studied. Psychological distress can occur alongside CRPS, but anxiety or depression does not mean the physical pain is imaginary or is solely caused by mental illness.

This combined view is often called a gene-environment interaction. It explains why family vulnerability and external events belong together in the explanation, while avoiding the misleading idea that either genetics or circumstances acts alone.

Diagnosis and testing pathways in Australia

CRPS is diagnosed from the clinical pattern, commonly using the Budapest criteria: symptoms in one region, continuing pain disproportionate to the triggering event, and signs affecting sensation, movement, blood flow, sweating, skin or nails. No blood test or routine genetic test can confirm the condition, and mild early cases may be mistaken for ordinary recovery after injury.

Australia’s Medicare-funded primary and specialist care commonly begins with a GP referral. People can be referred to a pain specialist or public hospital service, and eligible consultations may attract a Medicare rebate. Telehealth has also become a practical route for people who live far from metropolitan pain services.

Melbourne is home to multidisciplinary pain clinics and rehabilitation programs, while major Sydney public hospitals provide specialist pain assessments and coordinated treatment. Access varies between public and private services, and waiting times may be significant. Some medicines are subsidised through the Pharmaceutical Benefits Scheme, yet scripts, specialist fees and other out-of-pocket charges can still apply.

Treatment and rehabilitation strategies

There is no single cure for CRPS, but early, individualised treatment can reduce pain, improve movement and support daily function. A coordinated approach usually combines pain medicine, physiotherapy, occupational therapy, psychological support and careful management of triggers.

Treatments that a clinical team may consider include:

  • Pain medicines selected for neuropathic pain, with regular review of benefit and side effects.
  • Physiotherapy and occupational therapy that progress activity without forcing painful movement.
  • Graded motor imagery, mirror therapy and desensitisation techniques for some patients.
  • Selective use of nerve blocks, corticosteroids or other specialist interventions.

Rehabilitation and daily-management options include:

  • Pacing tasks, alternating activity with planned rest to avoid boom-and-bust cycles.
  • Maintaining comfortable movement while avoiding prolonged immobilisation or overprotection.
  • Monitoring swelling, skin temperature, sleep, nutrition and changes in limb use.
  • Using assistive devices and practical workplace adjustments when function is limited.

Because responses vary, treatment should not be escalated simply because one approach has failed. A multidisciplinary team can reassess the diagnosis, coordinate therapy and prioritise goals such as walking, sleep, self-care or return to work.

Supporting families and taking the next step

Genetic uncertainty can add emotional strain to the physical burden of CRPS. Some people worry they have passed the condition to children; others feel unsupported when symptoms are severe but visible tests are normal. Clear explanations, realistic goals and peer support can ease uncertainty without assigning blame.

Long-term personal accounts are valuable context. The experience described in living with RSD illustrates how symptoms, treatment choices and family responsibilities can shape life over many years. Such stories can help people feel less isolated, although individual outcomes do not predict how CRPS will progress for everyone.

If hereditary concerns are affecting your family, document relatives’ symptoms and diagnoses, then discuss the pattern with a GP. Ask whether a pain specialist or clinical genetics referral is appropriate, especially if several relatives are affected or have features of an inherited neuropathy. Seek rehabilitation and symptom-management support at the same time rather than waiting for genetic answers, and contact an Australian CRPS support organisation for practical peer connections.